Krane Funds Advisors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-983
| Closed | -$404K | – | 362 |
|
|
2022
Q1 | $404K | Buy |
983
+154
| +19% | +$63.3K | 0.02% | 224 |
|
|
2021
Q4 | $389K | Sell |
829
-91
| -10% | -$42.7K | 0.01% | 189 |
|
|
2021
Q3 | $391K | Sell |
920
-671
| -42% | -$285K | 0.01% | 232 |
|
|
2021
Q2 | $571K | Sell |
1,591
-12
| -0.7% | -$4.31K | 0.02% | 146 |
|
|
2021
Q1 | $452K | Buy |
1,603
+316
| +25% | +$89.1K | 0.02% | 195 |
|
|
2020
Q4 | $365K | Sell |
1,287
-148
| -10% | -$42K | 0.01% | 159 |
|
|
2020
Q3 | $394K | Sell |
1,435
-407
| -22% | -$112K | 0.02% | 133 |
|
|
2020
Q2 | $418K | Sell |
1,842
-1,424
| -44% | -$323K | 0.03% | 99 |
|
|
2020
Q1 | $497K | Sell |
3,266
-340
| -9% | -$51.7K | 0.03% | 88 |
|
|
2019
Q4 | $542K | Buy |
3,606
+69
| +2% | +$10.4K | 0.04% | 143 |
|
|
2019
Q3 | $502K | Buy |
3,537
+3,330
| +1,609% | +$473K | 0.04% | 180 |
|
|
2019
Q2 | $26K | Buy |
+207
| New | +$26K | ﹤0.01% | 134 |
|